Nephrocare Health Services Limited
Against an issue price of ₹460. Split- and bonus-adjusted official closes — a past move, never a forecast.
Nephrocare Health Services Limited was a mainboard initial public offer.
The book was open from 10 December 2025 to 12 December 2025.
The issue was priced at ₹460 a share, from a band of ₹438 to ₹460.
We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.
14 anchor investors were allotted shares before the book opened, worth ₹260 crore.
The shares listed on 17 December 2025.
The last official close on file is ₹752 (21 September 2026), which is 63.4% above the issue price.
It now trades as NEPHROPLUS, and its filed financials are on its company page.
Shares sold in the issue at ₹460 last closed at ₹751.6.
See NEPHROPLUS’s filed financials and price history →Official exchange closes, restated for splits, bonuses and rights issues since listing. A record of past price movement, not a forecast.
- Registrar
- KFin Technologies Limited
- Lead managers
- ICICI Securities Limited
- Ambit Private Limited
- IIFL Capital Services Limited and Nomura Financial Advisory and Securities (India) Private Limited
- Bidding opens10 Dec 2025
- Bidding closes12 Dec 2025
- Basis of allotmentnot published
Not published in the exchange feeds we ingest — we do not estimate it.
- Listing17 Dec 2025
We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.
We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.
Anchor investors are institutions allotted shares one working day before public bidding opens, at a price fixed then. Their shares are locked in for a set period.
| SBI HEALTHCARE OPPORTUNITIES FUND | ₹35 cr |
| DSP HEALTHCARE FUND | ₹28.5 cr |
| EASTSPRING INVESTMENTS - DRAGON PEACOCK FUND | ₹25 cr |
| ICICI PRUDENTIAL PHARMA HEALTHCARE AND DIAGANOSTICS (P.H.D) FUND | ₹25 cr |
| POLAR CAPITAL FUNDS PLC - HEALTHCARE OPPORTUNITIES FUND | ₹25 cr |
| THE PRUDENTIAL ASSURANCE COMPANY LIMITED | ₹25 cr |
| FIDELITY FUNDS - PACIFIC FUND | ₹22.6 cr |
| MANULIFE GLOBAL FUND - ASIAN SMALL CAP EQUITY FUND | ₹16.4 cr |
| BARODA BNP PARIBAS SMALL CAP FUND | ₹10.3 cr |
| BANDHAN SMALL CAP FUND | ₹10 cr |
| ICICI PRUDENTIAL RETIREMENT FUND-HYBRID AGGRESSIVE PLAN | ₹10 cr |
| SBI LIFE INSURANCE COMPANY LIMITED | ₹10 cr |
| HDFC LIFE INSURANCE COMPANY LIMITED | ₹10 cr |
| NEF - PACIFIC EQUITY | ₹7.4 cr |
From the issuer’s anchor allotment filing. A record of who was allotted what — not a recommendation.
- Anchor investors — first trancheSEBI ICDR 2018 Reg. 32(5)(b) — 50% of the anchor allocation, 30 days from allotment16 Jan 202650% of this tranche
- Anchor investors — second trancheSEBI ICDR 2018 Reg. 32(5)(a) — the remaining 50% of the anchor allocation, 90 days from allotment17 Mar 202650% of this tranche
- All other pre-issue capitalSEBI ICDR 2018 Reg. 17 — all other pre-issue capital, 6 months from allotment17 Jun 2026already free
- Promoters' minimum contributionSEBI ICDR 2018 Reg. 16(1)(a) — promoters' minimum contribution, 18 months from allotment17 Jun 2027whole tranche releases on this date
Computed from the SEBI ICDR 2018 lock-in rules, not disclosed by the issuer or the exchange. The regulation counts from the date of allotment, which no feed we ingest publishes, so these are counted from the listing date and fall at most two to three business days later than the true expiry.
The "Basis for Offer Price" chapter states the earnings the price was set against and the multiples it implies. We have not extracted it for this issue — several offer documents are served as .zip archives or as scanned pages with no text layer.
We have not extracted this section from the offer document for this issue yet. It is read from the abridged prospectus, and several offer documents are served as .zip archives or as scanned pages with no text layer.
We have not extracted this section from the offer document for this issue yet. It is read from the abridged prospectus, and several offer documents are served as .zip archives or as scanned pages with no text layer.
The offer document must name the listed companies the issuer considers comparable, and print their valuation figures beside its own. This is that list — the issuer’s choice of comparison, not ours.
| Company | P/E | P/B | RoNW | EPS | Income |
|---|---|---|---|---|---|
| Dr. Agarwal's Health Care Limited | — | — | 5.7% | 2.80 | — |
| Dr. Lal Path Labs Ltd. | — | — | 22.3% | 58.48 | — |
| Jupiter Life Line Hospitals Limited | — | — | 14.3% | 29.47 | — |
| Metropolis Healthcare Limited | — | — | 10.9% | 28.29 | — |
| Narayana Healthnot in our universe | — | — | 21.8% | 38.90 | — |
| Rainbow Children Hospitalnot in our universe | — | — | 16.6% | 23.97 | — |
| Vijaya Diagnosticsnot in our universe | — | — | 18.0% | 13.95 | — |
The issuer's own figures as printed at the head of the same table — its claim about itself, on the same basis as its claims about the companies below.
Figures as PRINTED by the issuer in its own offer document. The comparison set is the issuer's choice, not ours.
| Firm | Issues | Typical listing move | Below issue @30d | @90d | @180d |
|---|---|---|---|---|---|
Ambit Private Limited 2021 – 2025 | 7 1 measurable | -1.3% | 0 of 1 | 0 of 1 | 0 of 1 |
ICICI Securities Limited 2021 – 2026 | 87 12 measurable | +16.0% | 5 of 10 | 1 of 4 | 1 of 6 |
IIFL Capital Services Limited and Nomura Financial Advisory and Securities Private Limited 2025 – 2025 | 3 0 measurable | — | — | — | — |
| Firm | Issues | Typical listing move | Below issue @30d | @90d | @180d |
|---|---|---|---|---|---|
Kfin Technologies Limited 2021 – 2026 | 126 30 measurable | +7.9% | 8 of 18 | 2 of 5 | 2 of 5 |
A count of what happened to the other issues each firm was named on, computed from exchange closes. Not a rating, not a ranking, and not a view on the firm.
- Prospectus· PDF · exchange archive15 Dec 2025
- Draft red herring prospectus (DRHP)· PDF · exchange archive26 Jul 2025
- Anchor investor allotment· ZIP · exchange archive
- Financial ratios advertisement· ZIP · exchange archive
Filed with SEBI and the exchanges by the issuer. These are the source for every figure on this page.
Compiled from NSE and SEBI offer documents and exchange feeds. A description of the issue and of the bids received — not investment advice, and not a view on whether to apply. No grey-market premium, no allotment lookup and no listing-gain estimate is published here.